Evidence map›Paper›PMID 27755555›Full record

ArticlePLoS medicine2016

Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.

Leila Rooshenas, Daisy Elliott, Julia Wade, Marcus Jepson, Sangeetha Paramasivan, Sean Strong, Caroline Wilson, David Beard, Jane M Blazeby, Alison Birtle and 10 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 78 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 3 pooled it
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02841527 nacompletednot on this map

Gastric Bypass, Adjustable Gastric Banding or Sleeve Gastrectomy Surgery to Treat Severe and Complex Obesity: a Multi-centre Randomised Controlled Trial

TypeinterventionalSponsorUniversity of BristolRan2012 to 2023Enrolled1,351ConditionsObesity, Surgery, Quality of Life, Weight LossArmsGastric Band, Gastric Bypass, Sleeve Gastrectomy
NCT05547165 narecruitingnot on this mapstarted 2023, after this paper: background citation

Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants

TypeinterventionalSponsorNationwide Children's HospitalRan2023 to 2026Enrolled240ConditionsDuctus Arteriosus, PatentArmsPercutaneous Patent Ductus Arteriosus Closure (PPC), Responsive Management Intervention, Echocardiogram, cardiac
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 3 syntheses or guidelines pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

Leila RooshenasSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.ORCID http://orcid.org/0000-0002-6166-6055
Daisy ElliottSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Julia WadeSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Marcus JepsonSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Sangeetha ParamasivanSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.ORCID http://orcid.org/0000-0001-7329-9574
Sean StrongSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Caroline WilsonSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
David BeardNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Jane M BlazebySchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Alison BirtleRosemere Cancer Centre, Royal Preston Hospital, Preston, United Kingdom.
Alison HallidaySt George's, University of London, London, United Kingdom.
Chris A RogersClinical Trials and Evaluation Unit, Bristol Royal Infirmary, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.ORCID http://orcid.org/0000-0002-9624-2615
Rob SteinUniversity College London Hospitals, London, United Kingdom.ORCID http://orcid.org/0000-0003-2969-0415
Jenny L DonovanSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.ORCID http://orcid.org/0000-0002-6488-5472
ACST-2 study group
By-Band-Sleeve study group
Chemorad study group
CSAW study group
Optima prelim study group
POUT study group
University of Bristol · GBBristol Royal Infirmary · GBNational Institute for Health Research · GBNuffield Orthopaedic Centre · GBRoyal London Hospital · GBRoyal Preston Hospital · GBSt George's, University of London · GB

Funding

Cancer Research UK 13324Cancer Research UK 16781Department of Health 09/127/53Department of Health 10/34/01Department of Health PB-PG-0807-14131Medical Research Council MR/K025643/1Medical Research Council MR/L004933/2Versus Arthritis 19707
6 · The paper itself

Abstract

backgroundRandomised controlled trials (RCTs) are essential for evidence-based medicine and increasingly rely on front-line clinicians to recruit eligible patients. Clinicians' difficulties with negotiating equipoise is assumed to undermine recruitment, although these issues have not yet been empirically investigated in the context of observable events. We aimed to investigate how clinicians conveyed equipoise during RCT recruitment appointments across six RCTs, with a view to (i) identifying practices that supported or hindered equipoise communication and (ii) exploring how clinicians' reported intentions compared with their actual practices. METHODS AND

findingsSix pragmatic UK-based RCTs were purposefully selected to include several clinical specialties (e.g., oncology, surgery) and types of treatment comparison. The RCTs were all based in secondary-care hospitals (n = 16) around the UK. Clinicians recruiting to the RCTs were interviewed (n = 23) to understand their individual sense of equipoise about the RCT treatments and their intentions for communicating equipoise to patients. Appointments in which these clinicians presented the RCT to trial-eligible patients were audio-recorded (n = 105). The appointments were analysed using thematic and content analysis approaches to identify practices that supported or challenged equipoise communication. A sample of appointments was independently coded by three researchers to optimise reliability in reported findings. Clinicians and patients provided full written consent to be interviewed and have appointments audio-recorded. Interviews revealed that clinicians' sense of equipoise varied: although all were uncertain about which trial treatment was optimal, they expressed different levels of uncertainty, ranging from complete ambivalence to clear beliefs that one treatment was superior. Irrespective of their personal views, all clinicians intended to set their personal biases aside to convey trial treatments neutrally to patients (in accordance with existing evidence). However, equipoise was omitted or compromised in 48/105 (46%) of the recorded appointments. Three commonly recurring practices compromised equipoise communication across the RCTs, irrespective of clinical context. First, equipoise was overridden by clinicians offering treatment recommendations when patients appeared unsure how to proceed or when they asked for the clinician's expert advice. Second, clinicians contradicted equipoise by presenting imbalanced descriptions of trial treatments that conflicted with scientific information stated in the RCT protocols. Third, equipoise was undermined by clinicians disclosing their personal opinions or predictions about trial outcomes, based on their intuition and experience. These broad practices were particularly demonstrated by clinicians who had indicated in interviews that they held less balanced views about trial treatments. A limitation of the study was that clinicians volunteering to take part in the research might have had a particular interest in improving their communication skills. However, the frequency of occurrence of equipoise issues across the RCTs suggests that the findings are likely to be reflective of clinical recruiters' practices more widely.

conclusionsCommunicating equipoise is a challenging process that is easily disrupted. Clinicians' personal views about trial treatments encroached on their ability to convey equipoise to patients. Clinicians should be encouraged to reflect on personal biases and be mindful of the common ways in which these can arise in their discussions with patients. Common pitfalls that recurred irrespective of RCT context indicate opportunities for specific training in communication skills that would be broadly applicable to a wide clinical audience.

Indexed as

Clinical CompetencePatient SelectionRandomized Controlled Trials as TopicAttitude of Health PersonnelCommunicationHealth Knowledge, Attitudes, PracticeHumansPhysician-Patient RelationsPractice Patterns, Physicians'

Identifiers

PMID27755555
PMCPMC5068710
OpenAlexW2539317882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.